Rights and permissions
About this article
Cite this article
Abciximab use warranted in high-risk coronary angioplasty. Pharmacoecon. Outcomes News 50, 6 (1996). https://doi.org/10.1007/BF03269819
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03269819